79 related articles for article (PubMed ID: 11101908)
1. Evaluation of the in vitro Activity of Cefprozil Relative to Other Oral Antimicrobial Agents Against Bacteria in Clinical Specimens from Patients in São Paulo With Respiratory Tract Infections.
Sader HS; Cereda R; Oplustil C; Mendes CM
Braz J Infect Dis; 1998 Feb; 2(1):25-30. PubMed ID: 11101908
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000.
Koeth LM; Felmingham D; Jacobs MR; Rossi F
Int J Antimicrob Agents; 2004 Apr; 23(4):356-61. PubMed ID: 15081084
[TBL] [Abstract][Full Text] [Related]
3. [National Multicenter study of the in vitro activity of moxifloxacin against respiratory tract pathogens].
Loza E; Morosini M; Negri MC; Almaraz F; Cantón R; Baquero F
Rev Esp Quimioter; 2000 Mar; 13(1):37-43. PubMed ID: 10878536
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006.
Senok A; Al-Zarouni M; Al-Najjar J; Nublusi A; Panigrahi D
J Infect Dev Ctries; 2007 Dec; 1(3):296-302. PubMed ID: 19734608
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of clarithromycin, cefprozil, and other common oral antimicrobial agents against gram-positive and gram-negative pathogens.
Ritchie DJ; Hopefl AW; Milligan TW; Byrne JE; Maddux MS
Clin Ther; 1993; 15(1):107-13. PubMed ID: 8458040
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Antimicrobial Activity of Sparfloxacin, Relative to Other Oral Antibiotics Against 1,125 Bacterial Isolates from 10 Medical Centers in Brazil.
Mendes C; Sader H; Dainesi SM; Dias CG; Coscina A; Zoccoli C; da Silva JF ; Magalhães M; Teixeira LM; Souza HH; Oplustil CP; Andrade MG; Mimiça L; Mimiça I
Braz J Infect Dis; 1998 Feb; 2(1):18-24. PubMed ID: 11101907
[TBL] [Abstract][Full Text] [Related]
8. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):202-12. PubMed ID: 19321284
[TBL] [Abstract][Full Text] [Related]
9. Comparative In Vitro Activities of Moxifloxacin (Bay 12-8039) and Other Antimicrobial Agents Against Respiratory Tract Pathogens in Brazil.
Del' Alamo L ; Sampaio J; Miranda EA; Sader HS
Braz J Infect Dis; 1999 Dec; 3(6):215-219. PubMed ID: 11084671
[TBL] [Abstract][Full Text] [Related]
10. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
Sader HS; Jacobs MR; Fritsche TR
Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):5S-12S. PubMed ID: 17292577
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study.
Jacobs MR; Bajaksouzian S; Windau A; Good CE; Lin G; Pankuch GA; Appelbaum PC
Clin Lab Med; 2004 Jun; 24(2):503-30. PubMed ID: 15177851
[TBL] [Abstract][Full Text] [Related]
12. [Carrier rate of Streptococcus pneumoniae and susceptibility thereof to antimicrobial drugs among children in China: a surveillance study in Beijing, Shanghai, and Guangzhou 2000-2002].
Yao KH; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Shen XZ; Yang YH
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(28):1957-61. PubMed ID: 16313770
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
14. E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci.
Li J; Zhang Y; Chen Y; Hao F; Chen Y
Chin Med J (Engl); 2000 Jul; 113(7):628-31. PubMed ID: 11776034
[TBL] [Abstract][Full Text] [Related]
15. [Bactericide activity of cefadroxil comparated with amoxicillin-clavulanic acid, cefaclor and josamycin].
Etesse-Carsenti H; Caillon J; Mondain V; Durant J; Bernard E; Dellamonica P; Drugeon HB
Pathol Biol (Paris); 1991 Sep; 39(7):658-67. PubMed ID: 1758716
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
[TBL] [Abstract][Full Text] [Related]
17. Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin.
Koeth LM; Good CE; Saunders KA; Jakielaszek C
Int J Antimicrob Agents; 2004 Aug; 24(2):144-9. PubMed ID: 15288313
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Jacobs E; Dalhoff A; Korfmann G
Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
[TBL] [Abstract][Full Text] [Related]
19. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
[TBL] [Abstract][Full Text] [Related]
20. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
